Karlyn Martin

Charles Mininger @NUFeinbergMed and I discuss how we talk about patients with #SickleCell in @JournalGIM read it here: rdcu.be/dUDjH

@kush_r_desai @heatherlgornik @GBarnesMD @connors_md @MaryCushmanMD @IsthPresident @SVM_tweets *an Twitter novice 🙂

@kush_r_desai @heatherlgornik @GBarnesMD @connors_md @MaryCushmanMD @IsthPresident @SVM_tweets Yes- there was a abstract presented at ASH last weekend- about double odds of VTE compared with heterozygous PTGM or het FVL alone

Seeking input from #thrombosis #cvcoag #vascular communities: thoughts/experience (or even better) data on DOAC dosing for extended VTE prophylaxis for complex HZ Factor V Leiden + PT gene mutation? @GBarnesMD @connors_md @MaryCushmanMD @IsthPresident @SVM_tweets

Dream Heme team at #ASH23. But missing @MaryCushmanMD @UVMDeptMed @UVMcancercenter

Learning about PE AND how to take a selfie! Thanks ⁦@RosovskyRachel⁩ and #PERT2023 for a great conference!

Wearing my ⁦@AnticoagForum⁩ compression stockings on flight home from #Azores 😎☀️ AnticoagForum around the 🌍!

Great working with @KSanfilippoMD @RosovskyRachel @SCWollerMD @Lbkreuziger to report similar outcomes in low weight patients treated with DOAC vs Warfarin for VTE! authors.elsevier.com/a/1hP-1BEfCrHGr

Father daughter 🎾 National champions ! (Super senior division 😉)

AddThis | Home authors.elsevier.com/a/1gPdE5hx-WQq…

Apixaban, dabigatran, and warfarin - oh my! Looking for a quick & convenient way to compare different #DOACs & #warfarin?! Look no further than NATF's #anticoagulation comparison chart! See the full chart at hubs.la/Q01vTd1y0

Blood cells circulating at #ASH2022 party 😁

Frequent reason for consultation: What is the risk of bleeding for patients with elevated INR from chronic liver disease compared to those on warfarin? @KSanfilippoMD @JTHjournal onlinelibrary.wiley.com/doi/epdf/10.11…

This month's SIR Scan's graphic is from the IR Quarterly article "The COVID-CLOT connection: A review of thrombotic complications associated with #COVID19." Check out the design by Drs. Karlyn Martin and @kush_r_desai and read the full article. #IRad buff.ly/3LabxZ2

Names matter. Thrilled to share this Viewpoint we just published in @TheLancetHaem making the case that we should embrace the term "Classical Hematology" over "Benign" or Non-Malignant". Honored to have written this with Drs. Alison Loren and Alfred Lee! authors.elsevier.com/a/1e-2Z8MsWYC4…

Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis - Khan - - Journal of Thrombosis and Haemostasis onlinelibrary.wiley.com/doi/10.1111/jt…

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 0, No 0 acpjournals.org/doi/10.7326/M2…

Op-Ed: As a doctor in a COVID unit, I'm running out of compassion for the unvaccinated. Get the shot - Los Angeles Times apple.news/ARGBE2yDdRrKVo…

Studies show extended dosing of DOACs at therapeutic and prophylactic dosing reduce risk of recurrent VTE (NEJM 2013 & 2017). Do you do this? Take our survey to inform practice patterns! @NicoleKuderer @jzbos @connors_md @tzufeiwang intermountainhealthcare.org/redcapsurveys/…

What happened to the “flatten the curve” rally cry 😔

@SchimmelHeart Were antiXa levels therapeutic?

49yo M with #CAP c/b empyema s/p decortication c/b massive PE POD 6 undergoes successful cath dir lysis. Off pressors. Extubated. RV back to normal. Post CDL day 2 on heparin gets acute hypoxemia+shock again. New massive PE CT confirmed. What tx? Or respond with alternative.